Conviction Buy List

Renren Inc (NYSE: RENN) shares are feeling some of the negative blow back from Harbin Electric (NASDAQ: HRBN), as shares are off more than 6% today. Citron Research put out a research report on Harbin Electric earlier this morning calling the company a fraud, and that has shares down some 58%...

Youku.com Inc (NYSE: YOKU) shares are up more than 5% today, but are well off their highs after Goldman Sachs upgraded the stock this morning. Shares have fallen sharply in recent weeks, and Goldman defended the name, upgrading it to Buy from Neutral, but lowered the price target. The price...

Shares of Youku.com Inc (NYSE: YOKU) shares are jumping in pre-market trading, up more than 9% after the company was upgraded at Goldman Sachs to Buy from Neutral, and was added to the Conviction Buy List. The price target was moved to $55 At last check, shares of Youku.com were up $2.51 to $29....

Taiwan Semiconductor Mfg. Co. Ltd. (NYSE: TSM) shares are sharply higher today, gaining more than 4% after the company was added to Goldman Sachs Conviction Buy List this morning. At last check, shares were up 56 cents to $13.12, a gain of 4.46% on 17 million shares. The average daily volume is...

Goldman Sachs has Ford (NYSE: F) on its Conviction Buy List, and discusses the fallout from Japan on the automakers in a research note. In the note sent to investors, Goldman notes, "We believe investors will ultimately look through 2011 production shortfalls that are not demand-related. While we...

Goldman Sachs is adding Philip Morris International Inc. (NYSE: PM) to its Conviction Buy List, and it has a $74 price target on shares. In a note to clients, Goldman writes, "We are adding Philip Morris International (PM) to the Americas' Conviction Buy list with a $74 price target or 18% total...

Goldman Sachs is removing Allergan, Inc. (NYSE: AGN) from its  Conviction Buy List, but is still keeping shares rated at Buy. It has a $84 price target on shares.   In a note to investors, Goldman writes, "We are removing AGN from the Conviction Buy List and replacing it with...

Goldman Sachs is initiating coverage on Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) with a Conviction Buy and a $58 price target on shares. In a note sent to clients, Goldman writes, "We initiate on SLXP shares as Conviction Buy and view Salix as the most compelling small-cap growth story across our...

Goldman Sachs is reiterating its Conviction Buy rating on Kohl's Corporation (NYSE: KSS). In a note sent to investors, Goldman writes, "In our view, the finalization of the ASR removes any lingering uncertainty around the timing of the $1bn share repurchase. The only leg of the capital allocation...

Goldman Sachs is reiterating its Buy rating on PAREXEL International Corporation (NASDAQ: PRXL) and $28 price target. In a note sent to investors, Goldman writes, "Our positive view of an attractive clinical late-stage environment was strengthened again this quarter as we saw book-to-bills ratios...

Goldman Sachs sees 30% upside in shares of CIGNA Corp. (NYSE: CI), after it reported earnings. It has a Buy rating and a $45 price target on shares. In a research report sent to clients, Goldman writes, "We think a 9x forward multiple (as implied by our 6-month price target from our SOTP) is very...

Goldman Sachs has a research note on Texas Instruments Incorporated (NYSE: TXN) after the chip company reported earnings yesterday after the bell. It rates TXN on Conviction Buy List and has a $34 price target. In a note to clients, Goldman says, "We believe TI's guidance for seasonal 4Q revenue...